Dr. Poveda on the Results of the SOLO2 Trial in Ovarian Cancer
Andres Poveda, MD, discusses the results of the phase 3 SOLO2 trial in advanced ovarian cancer.
Immunotherapy Must Become More Precise and Personalized
Selecting the Appropriate CAR T-Cell Therapy for Patients with R/R LBCL
Is There a Potential Role for Rapcabtagene Autoleucel in R/R LBCL?
PD-1 Inhibitor Combinations, Alternative Therapeutic Approaches Are Moving the Needle in NSCLC
2 Clarke Drive Cranbury, NJ 08512